Dr. Ryan Abel, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,415 | 254 | 96.1% |
| Education | $180.99 | 2 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $454.54 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $374.49 | 23 | $0 (2024) |
| PFIZER INC. | $280.51 | 16 | $0 (2024) |
| Seagen Inc. | $255.80 | 12 | $0 (2023) |
| Janssen Biotech, Inc. | $223.23 | 15 | $0 (2024) |
| Novocure Inc. | $204.21 | 12 | $0 (2024) |
| Amgen Inc. | $183.91 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $178.58 | 9 | $0 (2024) |
| Daiichi Sankyo Inc. | $177.48 | 10 | $0 (2024) |
| Tempus AI, Inc | $141.51 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,532 | 87 | Novartis Pharmaceuticals Corporation ($251.46) |
| 2023 | $1,228 | 69 | Merck Sharp & Dohme LLC ($130.85) |
| 2022 | $1,277 | 69 | Amgen Inc. ($183.91) |
| 2021 | $133.99 | 9 | Janssen Biotech, Inc. ($36.95) |
| 2020 | $82.56 | 1 | Boston Scientific Corporation ($82.56) |
| 2019 | $95.18 | 6 | Janssen Biotech, Inc. ($26.22) |
| 2018 | $174.40 | 10 | Novocure Inc. ($63.98) |
| 2017 | $72.30 | 5 | INSYS Therapeutics Inc ($34.08) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/13/2024 | Genentech USA, Inc. | Tecentriq (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: BioOncology | ||||||
| 12/10/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 12/02/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $12.15 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $14.84 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/08/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.22 | General |
| 10/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: BioOncology | ||||||
| 09/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Hematology/Oncology | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,072 | 2,488 | $485,836 | $199,880 |
| 2022 | 18 | 1,107 | 2,602 | $481,884 | $199,081 |
| 2021 | 19 | 1,145 | 2,682 | $498,607 | $207,910 |
| 2020 | 21 | 964 | 2,655 | $451,664 | $188,205 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 79 | 248 | $87,792 | $35,743 | 40.7% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 97 | 974 | $81,816 | $33,388 | 40.8% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 79 | 83 | $65,404 | $26,362 | 40.3% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 38 | 40 | $48,160 | $19,762 | 41.0% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 79 | 83 | $35,192 | $14,428 | 41.0% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 110 | 116 | $36,656 | $14,116 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 97 | $20,564 | $10,583 | 51.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 74 | 74 | $23,902 | $9,626 | 40.3% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 102 | 312 | $19,032 | $7,702 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 77 | $11,550 | $5,579 | 48.3% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 54 | 111 | $13,542 | $5,156 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 106 | $10,388 | $4,704 | 45.3% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 23 | 25 | $10,575 | $4,311 | 40.8% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 28 | 28 | $5,516 | $2,267 | 41.1% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 29 | 31 | $4,774 | $1,935 | 40.5% |
| 77470 | Special radiation treatment | Office | 2023 | 21 | 21 | $4,326 | $1,662 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,500 | $1,332 | 38.1% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 28 | 37 | $2,553 | $1,023 | 40.1% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 11 | 11 | $594.00 | $202.40 | 34.1% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 83 | 261 | $92,394 | $38,085 | 41.2% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 108 | 965 | $81,060 | $32,986 | 40.7% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 78 | 83 | $65,404 | $26,191 | 40.0% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2022 | 78 | 83 | $35,192 | $14,508 | 41.2% |
| 77263 | Complex radiation therapy planning | Office | 2022 | 99 | 111 | $35,076 | $13,898 | 39.6% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2022 | 27 | 27 | $32,508 | $13,422 | 41.3% |
About Dr. Ryan Abel, MD
Dr. Ryan Abel, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1437385770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Abel, MD has received a total of $4,596 in payments from pharmaceutical and medical device companies, with $1,532 received in 2024. These payments were reported across 256 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($4,415).
As a Medicare-enrolled provider, Abel has provided services to 4,288 Medicare beneficiaries, totaling 10,427 services with total Medicare billing of $795,076. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Radiation Oncology
- Location Owensboro, KY
- Active Since 06/01/2009
- Last Updated 05/02/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1437385770
Products in Payments
- KEYTRUDA (Biological) $374.49
- TAGRISSO (Drug) $161.02
- Lenvima (Drug) $137.54
- LIBTAYO (Biological) $123.12
- XTANDI (Drug) $120.93
- ERLEADA (Drug) $113.73
- Optune (Device) $110.68
- IBRANCE (Drug) $103.88
- Enhertu (Drug) $89.10
- ENHERTU (Drug) $88.38
- SPACEOAR (Device) $82.56
- ADCETRIS (Biological) $81.92
- Oncology (Device) $81.38
- IMBRUVICA (Drug) $68.19
- BRUKINSA (Drug) $65.97
- KISQALI (Drug) $63.45
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) $63.44
- Kyprolis (Drug) $63.00
- PLUVICTO (Drug) $62.40
- SCEMBLIX (Drug) $60.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Owensboro
Dr. Berhanemeskel Nesketa, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $16,490
Jessica Raque, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $12,031
Rebecca Mckindles, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $11,446
Heather Condon, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $10,668
Bridget Evans
Student in an Organized Health Care Education/Training Program — Payments: $2,597
Caroline Germany, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,077